KOD•prnewswire•
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
Summary
PALO ALTO, Calif., Dec. 16, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced the pricing of an upsized underwritten public...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 17, 2025 by prnewswire